Innate Pharma announces its participation in the Life Sciences Van Lanschot Kempen Conference
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that members of its executive team are scheduled to participate in the upcoming investor conference, detailed below:
Life Sciences Van Lanschot Kempen ConferenceEvent dates: April 1 – 3, 2025 | Amsterdam, Netherlands
About Innate Pharma
Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three therapeutic approaches: multi-specific NK Cell Engagers via its ANKET® (Antibody-based NK cell Engager Therapeutics) proprietary platform, Antibody Drug Conjugates (ADC) and monoclonal antibodies (mAbs).
Innate's portfolio includes several ANKET® drug candidates to address multiple tumor types as well as IPH4502, a differentiated ADC in development in solid tumors. In addition, anti-KIR3DL2 mAb lacutamab is developed in advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, and anti-NKG2A mAb monalizumab is developed with AstraZeneca in non-small cell lung cancer.
Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research and development for the benefit of patients.
Headquartered in Marseille, France with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
Learn more about Innate Pharma at www.innate-pharma.com and follow us on LinkedIn and X.
Information about Innate Pharma shares
ISIN code Ticker code LEI
FR0010331421
Euronext: IPH Nasdaq: IPHA
9695002Y8420ZB8HJE29
Disclaimer on forward-looking information and risk factors
This press release contains certain forward-looking statements, including those within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. The use of certain words, including "anticipate," "believe," "can," "could," "estimate," "expect," "may," "might," "potential," "expect" "should," "will," or the negative of these and similar expressions, is intended to identify forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Company's reliance on third parties to manufacture its product candidates, the Company's commercialization efforts and the Company's continued ability to raise capital to fund its development. For an additional discussion of risks and uncertainties, which could cause the Company's actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the Universal Registration Document filed with the French Financial Markets Authority ("AMF"), which is available on the AMF website http://www.amf-france.org or on Innate Pharma's website www.innate-pharma.com, and public filings and reports filed with the U.S. Securities and Exchange Commission ("SEC"), including the Company's Annual Report on Form 20-F for the year ended December 31, 2023, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public by the Company. References to the Company's website and the AMF website are included for information only and the content contained therein, or that can be accessed through them, are not incorporated by reference into, and do not constitute a part of, this press release.
In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by the Company or any other person that the Company will achieve its objectives and plans in any specified time frame or at all. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250324442720/en/
Contacts
For additional information, please contact:Investors Innate Pharma Henry WheelerTel.: +33 (0)4 84 90 32 88Henry.wheeler@innate-pharma.fr
Media Relations NewCap Arthur RouilléTel.: +33 (0)1 44 71 00 15innate@newcap.eu
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Why Rigetti Computing Stock Is Sinking Today
Key Points Q2 revenue was $1.8 million, down roughly 42% year over year; net loss neared $40 million. Soft jobs data and hotter-than-expected inflation data weighed on risk assets like quantum stocks. 10 stocks we like better than Rigetti Computing › Shares of Rigetti Computing (NASDAQ: RGTI) are sinking on Tuesday, down 8.7% as of 2:46 p.m. ET. The drop comes as the S&P 500 loses 0.7% and the Nasdaq Composite loses 1.5%. The quantum computing company's stock is continuing its slide after its recent earnings failed to impress investors and as macro concerns about the direction of the economy are leading investors to jump out of risky stocks. Rigetti Computing stock drops on weak Q2 and macro jitters Last week, Rigetti released its Q2 report, revealing that its sales and earnings were down significantly year over year. The company's $1.8 million in revenue was nearly 42% less than last year in the same period, and its net income dropped nearly 220% as the company lost nearly $40 million in the quarter. While the loss was exacerbated by some one-off accounting charges, the performance still showed how far the company is from justifying its current market cap of nearly $5 billion. Adding to the pain, recent economic data is putting pressure on riskier stocks like Rigetti. The latest jobs report shows the economy may be slowing, while at the same time, inflation numbers came in higher than expected. Investors should be cautious The company did share some promising operational updates and leaps in its technological development in its earnings release, but I believe we are likely many, many years, if not decades, away from viable quantum computing. Despite this, Rigetti and other quantum computing companies are reaching multibillion-dollar valuations already. I think there is a major disconnect here, and quantum investors may get burned if the economy does really take a dive. Should you buy stock in Rigetti Computing right now? Before you buy stock in Rigetti Computing, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Rigetti Computing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,633!* Now, it's worth noting Stock Advisor's total average return is 1,076% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Johnny Rice has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Rigetti Computing Stock Is Sinking Today was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Top analysts pick 3 favorite crypto mining stocks
Top analysts pick 3 favorite crypto mining stocks originally appeared on TheStreet. One of the foundational industries in the blockchain and crypto space, crypto mining has firmly established itself as a prominent player in the global technology sector. Pioneering companies from the crypto mining industry have gone on to become one of the most dependable bets in the markets. To put it simply, crypto mining is the process of using high-end computers to solve complex cryptographic puzzles to validate and add transactions to a blockchain network. It requires a lot of computing power to solve these functions, and the reward in the form of newly minted crypto assets is quite lucrative. That is why we have witnessed an extraordinary emergence of crypto mining firms in several parts of the world, but the U.S. takes the lead in mining operations. Despite the doubts surrounding the crypto industry in general, these mining companies have cemented themselves as emergent leaders in the global technology market over the years. Of late, such firms have also invited the attention of several well-established giants and even succeeded in persuading them to open their coffers to support crypto mining operations. Institutions open coffers for crypto mining Whether it's the Trump family or Jack Dorsey or Google, nobody has been able to escape the charm of the lucrative industry. But the traditional tech industry embracing the disruptive crypto industry wouldn't seem like an unusual phenomenon if we carefully look at the numbers. After all, Bitcoin — the premier cryptocurrency that the crypto mining industry primarily focuses on — has been hitting new all-time highs over the past few months. Bitcoin mining profits reached their highest monthly mark in July since the last halving in April 2024, JP Morgan analysts wrote in a recent note. Miners earned as much as an average of $57,400 per EH/s in daily block reward revenue the last month. In this story, we look at three crypto mining stocks that the leading analysts are talking about. TeraWulf Inc. TeraWulf Inc. (Nasdaq: WULF) is a Bitcoin mining and high-performance computing (HPC) firm that recently came under the spotlight following Google, Alphabet's (Nasdaq: GOOGL) iconic tech brand, acquiring a 14% stake in it. Google is now the largest shareholder of TeraWulf. 'Fluidstack's decision to expand so soon after our initial agreement speaks volumes about the quality, readiness, and scalability of our infrastructure,' TeraWulf CTO Nazar Khan said of the latest expansion drive with AI cloud provider Fluidstack. On Aug. 8, TeraWulf revealed that its Bitcoin mining capacity grew 45.5% YoY to 12.8 EH/s during Q2 2025. It mined 485 BTC during Q2 2025, as compared to 699 BTC during Q2 2024. Cantor Fitzgerald analyst Brett Knoblauch has raised the price target on WULF from $11 to $14 and maintained an "Overweight" rating. The stock was trading at $9.02 at press time, down 3.5% a day. HIVE Digital HIVE Digital Technologies (Nasdaq: HIVE) is one of the earliest and most well-established Bitcoin mining firms in the world, which has a global footprint in Canada, Sweden, and Paraguay. On July 8, the firm revealed that its monthly Bitcoin production rose 18% in June. It is counting on its burgeoning Phase 2 unit in Paraguay and AI technology. Roth Capital Markets analyst Darren Aftahi has kept the price target on HIVE at $6 and maintained a "Buy" rating. The stock was trading at $2.3801 at the time of writing, up 0.4262% a day. Riot Platforms Riot Platforms (Nasdaq: RIOT) is a leading Bitcoin mining firm that is headquartered in Colorado. It also focuses on developing a portion of its power capacity for AI and HPC uses. On July 31, the firm revealed that its Bitcoin production grew more than 65% YoY during Q2 2025. Riot mined 1,426 BTC during the last quarter. Cantor Fitzgerald's Brett Knoblauch has kept the price target on RIOT at $24 and maintained a "Buy rating." The stock was trading at $12.15, down 1.34% a day. Top analysts pick 3 favorite crypto mining stocks first appeared on TheStreet on Aug 19, 2025 This story was originally reported by TheStreet on Aug 19, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Q2 Earnings Highs And Lows: Advance Auto Parts (NYSE:AAP) Vs The Rest Of The Auto Parts Retailer Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let's take a look at how Advance Auto Parts (NYSE:AAP) and the rest of the auto parts retailer stocks fared in Q2. Cars are complex machines that need maintenance and occasional repairs, and auto parts retailers cater to the professional mechanic as well as the do-it-yourself (DIY) fixer. Work on cars may entail replacing fluids, parts, or accessories, and these stores have the parts and accessories or these jobs. While e-commerce competition presents a risk, these stores have a leg up due to the combination of broad and deep selection as well as expertise provided by sales associates. Another change on the horizon could be the increasing penetration of electric vehicles. The 5 auto parts retailer stocks we track reported a mixed Q2. As a group, revenues beat analysts' consensus estimates by 0.9%. In light of this news, share prices of the companies have held steady as they are up 1.6% on average since the latest earnings results. Weakest Q2: Advance Auto Parts (NYSE:AAP) Founded in Virginia in 1932, Advance Auto Parts (NYSE:AAP) is an auto parts and accessories retailer that sells everything from carburetors to motor oil to car floor mats. Advance Auto Parts reported revenues of $2.01 billion, down 7.7% year on year. This print exceeded analysts' expectations by 1%. Despite the top-line beat, it was still a slower quarter for the company with full-year EPS guidance missing analysts' expectations significantly and a significant miss of analysts' EBITDA estimates. "The Advance team delivered solid second-quarter results, with both sales and operating margin at the upper end of our expectations. I want to thank the team for their dedication and hard work throughout the quarter," said Shane O'Kelly, president and chief executive officer. Advance Auto Parts delivered the slowest revenue growth and weakest full-year guidance update of the whole group. Unsurprisingly, the stock is down 9.1% since reporting and currently trades at $56.21. Read our full report on Advance Auto Parts here, it's free. Best Q2: Monro (NASDAQ:MNRO) Started as a single location in Rochester, New York, Monro (NASDAQ:MNRO) provides common auto services such as brake repairs, tire replacements, and oil changes. Monro reported revenues of $301 million, up 2.7% year on year, outperforming analysts' expectations by 1.7%. The business had an exceptional quarter with a beat of analysts' EPS estimates and an impressive beat of analysts' EBITDA estimates. Monro scored the biggest analyst estimates beat among its peers. Although it had a fine quarter compared its peers, the market seems unhappy with the results as the stock is down 5.7% since reporting. It currently trades at $15.40. Is now the time to buy Monro? Access our full analysis of the earnings results here, it's free. AutoZone (NYSE:AZO) Aiming to be a one-stop shop for the DIY customer, AutoZone (NYSE:AZO) is an auto parts and accessories retailer that sells everything from car batteries to windshield wiper fluid to brake pads. AutoZone reported revenues of $4.46 billion, up 5.4% year on year, exceeding analysts' expectations by 1.1%. Still, it was a slower quarter as it posted a miss of analysts' EBITDA estimates and a slight miss of analysts' gross margin estimates. Interestingly, the stock is up 5.5% since the results and currently trades at $4,040. Read our full analysis of AutoZone's results here. O'Reilly (NASDAQ:ORLY) Serving both the DIY customer and professional mechanic, O'Reilly Automotive (NASDAQ:ORLY) is an auto parts and accessories retailer that sells everything from fuel pumps to car air fresheners to mufflers. O'Reilly reported revenues of $4.53 billion, up 5.9% year on year. This print met analysts' expectations. Taking a step back, it was a slower quarter as it produced a miss of analysts' EBITDA estimates and full-year EPS guidance slightly missing analysts' expectations. O'Reilly pulled off the fastest revenue growth and highest full-year guidance raise, but had the weakest performance against analyst estimates among its peers. The stock is up 6.8% since reporting and currently trades at $102. Read our full, actionable report on O'Reilly here, it's free. Genuine Parts (NYSE:GPC) Largely targeting the professional customer, Genuine Parts (NYSE:GPC) sells auto and industrial parts such as batteries, belts, bearings, and machine fluids. Genuine Parts reported revenues of $6.16 billion, up 3.4% year on year. This number beat analysts' expectations by 0.9%. It was a satisfactory quarter as it also put up an impressive beat of analysts' gross margin estimates. The stock is up 10.7% since reporting and currently trades at $137.14. Read our full, actionable report on Genuine Parts here, it's free. Market Update The Fed's interest rate hikes throughout 2022 and 2023 have successfully cooled post-pandemic inflation, bringing it closer to the 2% target. Inflationary pressures have eased without tipping the economy into a recession, suggesting a soft landing. This stability, paired with recent rate cuts (0.5% in September 2024 and 0.25% in November 2024), fueled a strong year for the stock market in 2024. The markets surged further after Donald Trump's presidential victory in November, with major indices reaching record highs in the days following the election. Still, questions remain about the direction of economic policy, as potential tariffs and corporate tax changes add uncertainty for 2025. Want to invest in winners with rock-solid fundamentals? Check out our Hidden Gem Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
